Evidence map›Paper›PMID 28428889›Full record

ArticleHuman genome variation2016

Detection of 1p36 deletion by clinical exome-first diagnostic approach.

Miki Watanabe, Yasunobu Hayabuchi, Akemi Ono, Takuya Naruto, Hideaki Horikawa, Tomohiro Kohmoto, Kiyoshi Masuda, Ryuji Nakagawa, Hiromichi Ito, Shoji Kagami and 1 more

Open access · goldAbstract read
In one paragraph

Article in Human genome variation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Molecular diagnosis of an infant withHuman genome variation · 2020
    Article
  5. Novel compound heterozygousHuman genome variation · 2019
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. NovelHuman genome variation · 2017
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Miki WatanabeDepartment of Human Genetics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Yasunobu HayabuchiDepartment of Paediatrics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Akemi OnoDepartment of Paediatrics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Takuya NarutoDepartment of Human Genetics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Hideaki HorikawaDepartment of Human Genetics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Tomohiro KohmotoDepartment of Human Genetics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Kiyoshi MasudaDepartment of Human Genetics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Ryuji NakagawaDepartment of Paediatrics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Hiromichi ItoDepartment of Paediatrics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Shoji KagamiDepartment of Paediatrics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Issei ImotoDepartment of Human Genetics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Tokushima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although chromosome 1p36 deletion syndrome is considered clinically recognizable based on characteristic features, the clinical manifestations of patients during infancy are often not consistent with those observed later in life. We report a 4-month-old girl who showed multiple congenital anomalies and developmental delay, but no clinical signs of syndromic disease caused by a terminal deletion in 1p36.32-p36.33 that was first identified by targeted-exome sequencing for molecular diagnosis.

Identifiers

PMID28428889
PMCPMC5381605
OpenAlexW2347329500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.